CT-219 Clinical Evaluation of Fast-in-Time (FIT) Anti-CD19 CAR T—a Non-Viral, 2-Day Rapid Manufacture CAR T-Cell Therapy for B-Cell Malignancies
Li, Ping, Ge, Jian, Ye, Shiguang, Zhou, Lili, Gong, Yiming, Ruan, Huaying, Kouros-Mehr, Hosein, Liang, Aibing
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
Clinical Evaluation of Fast-in-Time (FIT) Anti-CD19 CAR T—A Non-Viral, 2-Day Rapid Manufacture CAR T-Cell Therapy for B-Cell Malignancies
Li, Ping, Ge, Jian, Ye, Shiguang, Zhou, Lili, Gong, Yiming, Ruan, Huaying, Kouros-Mehr, Hosein, Liang, Aibing
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
Low Dose of Human scFv-Derived BCMA-Targeted CAR-T Cells Achieved Fast Response and High Complete Remission in Patients with Relapsed/Refractory Multiple Myeloma
Jiang, Songfu, Jin, Jie, Hao, Siguo, Yang, Min, Chen, Linjun, Ruan, Huaying, Xiao, Jun, Wang, Wei, Li, Zonghai, Yu, Kang
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
A phase I study of anti-GPC3 chimeric antigen receptor modified T cells (GPC3 CAR-T) in Chinese patients with refractory or relapsed GPC3+ hepatocellular carcinoma (r/r GPC3+ HCC)
Zhai, Bo, Shi, Donghua, Gao, Huiping, Qi, Xingxing, Jiang, Hua, Zhang, Yuan, Chi, Jiachang, Ruan, Huaying, Wang, Huamao, Ru, Qinhua Cindy, Li, Zonghai
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article